ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HROW Harrow Inc

10.95
0.125 (1.15%)
Mar 01 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Harrow Inc HROW NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.125 1.15% 10.95 16:25:01
Open Price Low Price High Price Close Price Prev Close
10.83 10.68 11.00 10.95 10.825
more quote information »

Recent News

Date Time Source Heading
2/21/202419:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202419:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/15/202416:15EDGAR2Form 8-K - Current report
2/15/202416:01BWHarrow Licenses Canadian Rights to Apotex for Five Branded..
2/09/202416:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/08/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/29/202416:30EDGAR2Form 8-K - Current report
1/29/202415:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/29/202407:00BWHarrow Announces New Appointments to its Board of Directors
1/11/202407:00BWHarrow Announces Availability of VEVYE® (Cyclosporine..
1/09/202410:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/03/202408:00EDGAR2Form 8-K - Current report
1/03/202407:15BWMelt Pharmaceuticals Provides Corporate Update
1/03/202407:00BWHarrow Partners with Leading Healthcare Market Access..
11/29/202307:00BWHarrow Completes Transfer of the TRIESENCE® New Drug..
11/20/202307:00BWHarrow to Present at Two Investor Conferences in November
11/16/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/14/202319:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202316:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202316:34EDGAR2Form 8-K - Current report
11/13/202316:01BWHarrow Announces Third Quarter 2023 Financial Results
11/03/202316:52EDGAR2Form 8-K - Current report
10/30/202308:00BWHarrow Will Release Third Quarter 2023 Financial Results on..
10/24/202307:00BWHarrow Completes Transfer of NDAs and Launches FLAREX®,..
9/29/202316:01EDGAR2Form 8-K - Current report
9/29/202308:00BWHarrow Health, Inc. Changes Corporate Name to Harrow, Inc.
9/26/202308:00BWMelt Pharmaceuticals Announces Exclusive Development and..
9/20/202318:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/15/202307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/09/202316:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/202316:05EDGAR2Form 8-K - Current report
8/09/202316:01BWHarrow Announces Second Quarter 2023 Financial Results
7/31/202307:00BWHarrow Launches VIGAMOX® in the U.S.
7/26/202309:00BWHarrow to Announce Second Quarter 2023 Financial Results on..
7/21/202316:02EDGAR2Form 8-K - Current report
7/20/202319:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/20/202319:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/19/202317:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
7/19/202307:00BWHarrow Prices $60 Million Public Offering of Common Stock
7/18/202322:55BWHarrow erwirbt US-amerikanische und kanadische..
7/18/202317:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
7/18/202317:00BWHarrow Acquires Santen’s Branded Ophthalmic Portfolio
7/18/202316:59EDGAR2Form 8-K - Current report
7/18/202316:05BWHarrow Provides Select Preliminary Second Quarter 2023..
7/18/202316:04BWHarrow Announces Proposed Public Offering of Common Stock
7/18/202316:01BWHarrow Acquires U.S. and Canadian Commercial Rights to..
5/17/202308:00BWHarrow to Participate in B. Riley Securities 23rd Annual..
5/11/202316:01BWHarrow Announces First Quarter 2023 Financial Results
5/04/202308:00BWHarrow to Launch FDA-Approved IHEEZO™ at the 2023 American..
5/02/202307:00BWHarrow Launches ILEVRO®, NEVANAC®, and MAXIDEX® in the U.S.

Your Recent History

Delayed Upgrade Clock